... Пекин.NEW—Preliminary results from Russian trials find that vaccine candidates led to no serious adverse events and elicit antibody response Thread (1/8) — The Lancet (@TheLancet)
Журнал Публикува - Новини
... Пекин.NEW—Preliminary results from Russian trials find that vaccine candidates led to no serious adverse events and elicit antibody response Thread (1/8) — The Lancet (@TheLancet)